Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Pharmaceutics|May 4, 2026
Fire in an Icy Desert: Oncolytic Virotherapy for Pancreatic AdenocarcinomaAlessandra Rossetto, Alberto RealePharmaceutics|December 28, 2021
Giving Oncolytic Viruses a Free Ride: Carrier Cells for Oncolytic VirotherapyAlberto Reale, Arianna Calistri, Jennifer AltomonteCells|March 6, 2021
Why Cells and Viruses Cannot Survive without an ESCRTArianna Calistri, Alberto Reale, Giorgio Palù, et al.Journal of Cellular Physiology|August 18, 2017
The silent enemy: Celiac disease goes viralAlberto Reale, Marta Trevisan, Gualtiero Alvisi, et al.Journal of Cellular Physiology|November 19, 2016
4th European Seminars in Virology on Oncogenic and Oncolytic Viruses, in Bertinoro (Bologna), ItalyAlberto Reale, Lorenzo Messa, Adriana Vitiello, et al.Infectious Agents and Cancer|February 23, 2019
Perspectives on immunotherapy via oncolytic virusesAlberto Reale, Adriana Vitiello, Valeria Conciatori, et al.Materials Today. Bio|November 17, 2025
Redirecting the route: Monocyte-mediated delivery of oHSV-1 across a human BBB-on-chip modelSara Micheli, Alberto Reale, Alessandra Rossetto, et al.International Journal of Molecular Sciences|June 10, 2023
Human Monocytes Are Suitable Carriers for the Delivery of Oncolytic Herpes Simplex Virus Type 1 In Vitro and in a Chicken Embryo Chorioallantoic Membrane Model of CancerAlberto Reale, Lea Krutzke, Massimiliano Cadamuro, et al.Biomedicines|July 27, 2024
Simultaneous Expression of Different Therapeutic Genes by Infection with Multiple Oncolytic HSV-1 VectorsAdriana Vitiello, Alberto Reale, Valeria Conciatori, et al.Molecular Therapy. Oncology|September 16, 2025
Oncolytic HSV-1 expressing FLT3L kills melanoma, glioblastoma, and pancreatic cancer cells in vitro and induces immunogenic cell deathSandra Tuyaerts, Xenia Geeraerts, Alberto Reale, et al.Pageof 2